ABCC2 and metabolic dysfunction-associated steatotic liver disease: NAFLD progression is associated with reduced expression and function of several hepatic uptake transporters, upregulation of many efflux transporters, downregulation of cholesterol efflux transporters, and mislocalization of the canalicular transporter ABCC2.[49]